asianews.network ·
trust deficit grows over free medicines in nepal
Topic context
This topic has been covered 355361 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article reports a trust deficit in Nepal's free medicine program due to quality concerns from low-bid procurement and lack of testing. This affects the pharmaceutical supply chain in Nepal, potentially reducing demand for government-procured drugs and increasing private pharmacy sales. The mechanism is regulatory (procurement policy) and demand_spike for private sector drugs. Impact is Nepal-specific, with no direct global commodity price effect.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Government increased free essential medicines from 70 to 98 since 2015.
- In 2025, only 648 out of over 24,000 medicines were quality tested.
- No quality checks on free essential list medicines.
- Procurement favors low-bid contracts, compromising quality.
- Patients and doctors distrust free medicines, preferring private pharmacies.
Nepal pharma: sustained shift to private pharmacies, revenue up 2-5% over 1-4 weeks.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- PHARMA_BIOTECHmid
- PHARMA_BIOTECHshort
